EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

ACMG / AMP ‐Based Variant Classification of a Novel HBA2 Variant ( HBA2 : C.297del, Hb Taiping) in Compound Heterozygosity With Hb Adana ( HBA2 :C. 179G >A) Causing Non‐Deletional Hb H Disease

Norafiza Mohd Yasin, Suguna Somasundram, Syahzuwan Hassan, Nur Aisyah Aziz iD, Faidatul Syazlin Abdul Hamid, Ezzanie Suffya Zulkefli, Nor Nazuha Mohamad, Chin Ming Lee, Mohd Nazif Darawi, Thessalia Papasavva, Coralea Stephanou, Petros Kountouris und 3 weitere

International Journal of Laboratory Hematology · 2026

DOI: 10.1111/ijlh.70037 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Laboratory Hematology, 2026. Verfasst von Norafiza Mohd Yasin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Unit, Cancer Research Centre (CaRC), Institute for Medical Research (IMR), National Institute for Health (NIH) Setia Alam, Setia Alam, Se…. Hauptthemen laut MEDLINE: alpha-Thalassemia, Hemoglobins, Abnormal, Heterozygote, Hemoglobin A2. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate classification of novel globin gene variants is critical for the diagnosis and management of thalassaemia. The adaptation of ACMG/AMP guidelines for globin genes represents an important step toward standardising variant interpretation and enhancing clinical utility in the field. This study reports the haematological and molecular characteristics of a novel α2‐globin variant identified in a Malay family.

Methods

A Malay family from Taiping, Perak, Malaysia, with a history of α‐thalassaemia, was recruited for this study. The proband's phenotype was assessed through comprehensive haematological analysis and clinical evaluation. Known α‐thalassaemia deletions and non‐deletional mutations were screened using gap‐PCR and ARMS‐PCR. Sanger sequencing of the HBA genes was conducted to characterise the proband's genotype in detail.

Results

A novel pathogenic HBA2 variant was identified, expanding the known mutational spectrum of α‐thalassaemia. This variant introduces a premature stop codon, occurs in trans with a known pathogenic allele associated with a significant clinical phenotype, segregates with the disease in the family, and is absent from major population databases. Based on haematological data, molecular findings, in silico predictions, and protein modeling, the variant meets the ACMG/AMP criteria for pathogenicity adapted for α‐globin genes. We have designated this variant Hb Taiping, named after the location of its discovery. Its accurate classification is vital for carrier screening, genetic counselling, and prenatal diagnosis, thereby supporting improved clinical management.

Conclusion

This study identifies and characterises a novel α‐globin gene variant, Hb Taiping, in a Malay family with α‐thalassaemia. The discovery contributes to the growing body of pathogenic mutations linked to α‐thalassaemia and underscores the importance of precise variant classification for effective diagnosis, risk assessment, and genetic counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-ThalassemiaHemoglobins, AbnormalHeterozygoteHemoglobin A2Mutationalpha-GlobinsHumansFemaleMalePedigreeAdultPhenotype

Stichwörter der Autor:innen

alpha‐thalassaemianovel variantvariant classification

Substanzen

Hemoglobins, AbnormalHemoglobin A2hemoglobin Adanaalpha-Globins

Autor:innen und Institutionen

  • Haematology Unit, Cancer Research Centre (CaRC), Institute for Medical Research (IMR), National Institute for Health (NIH) Setia Alam, Setia Alam, Selangor, Malaysia.
  • Department of Clinical Genetics/GD, Leiden University Medical Centre, Leiden, the Netherlands.
  • Haematology Unit, Pathology Department, Hospital Taiping, Taiping, Perak, Malaysia.
  • Paediatric Unit, Department of Medicine, Hospital Taiping, Taiping, Perak, Malaysia.
  • Department of Medical Diagnostics, Faculty of Health Sciences, University Selangor, Shah Alam, Selangor, Malaysia.
  • Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

ORCID-Profile: Nur Aisyah Aziz, Cornelis L Harteveld

Förderung

  • European Cooperation in Science and Technology

Zitieren

APA

Yasin, N. M., Somasundram, S., Hassan, S., Aziz, N. A., Hamid, F. S. A., Zulkefli, E. S., Mohamad, N. N., Lee, C. M., Darawi, M. N., Papasavva, T., Stephanou, C., Kountouris, P., Arkesteijn, S. J. G., Koopman, T., & Harteveld, C. L. (2026). ACMG / AMP ‐Based Variant Classification of a Novel HBA2 Variant ( HBA2 : C.297del, Hb Taiping) in Compound Heterozygosity With Hb Adana ( HBA2 :C. 179G >A) Causing Non‐Deletional Hb H Disease. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.70037

Vancouver

Yasin NM, Somasundram S, Hassan S, Aziz NA, Hamid FSA, Zulkefli ES, et al. ACMG / AMP ‐Based Variant Classification of a Novel HBA2 Variant ( HBA2 : C.297del, Hb Taiping) in Compound Heterozygosity With Hb Adana ( HBA2 :C. 179G >A) Causing Non‐Deletional Hb H Disease. International Journal of Laboratory Hematology. 2026. doi:10.1111/ijlh.70037

BibTeX
@article{Yasin2026,
  author = {Yasin, Norafiza Mohd and Somasundram, Suguna and Hassan, Syahzuwan and Aziz, Nur Aisyah and Hamid, Faidatul Syazlin Abdul and Zulkefli, Ezzanie Suffya and Mohamad, Nor Nazuha and Lee, Chin Ming and Darawi, Mohd Nazif and Papasavva, Thessalia and Stephanou, Coralea and Kountouris, Petros and Arkesteijn, Sandra J G and Koopman, Tamara and Harteveld, Cornelis L},
  title = {ACMG / AMP ‐Based Variant Classification of a Novel HBA2 Variant ( HBA2 : C.297del, Hb Taiping) in Compound Heterozygosity With Hb Adana ( HBA2 :C. 179G >A) Causing Non‐Deletional Hb H Disease},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  doi = {10.1111/ijlh.70037}
}
Kostenlos starten →